Taken together, these results further suggested the molecular mechanism by which CD36 controls tumor proliferation and glycolysis via inhibiting GPC4-mediated β-catenin/c-myc signaling in colorectal tumorigenesis (Fig. 7f). The gene discussed is CD36; the disease is neoplasm.